🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
As part of the ageing process muscles become weaker. One of the reasons for...
Status
Unknown
Location
University of East Anglia
Start Date
2024-02
Trial ID
NCT06262711
In the present study, Sponsor aim to evaluate the effects of EnXtra® as to ...
Status
Completed
Location
Dr D Y Patil medical college
Start Date
2022-10-10
Trial ID
NCT05586880
Treatments Being Tested
The present study is a randomized, double-blind, placebo-controlled, compar...
Status
Unknown
Location
Life care hospital
Start Date
2024-04-05
Trial ID
NCT06355661
Treatments Being Tested
A Randomized, Double-Blind, Two-Arm, Placebo-Controlled Clinical Study to a...
Status
Not Yet Recruiting
Location
Pawna Hospital
Start Date
2024-10-15
Trial ID
NCT06658717
Previous work demonstrated that inhaled hypertonic saline (HS) reduces exac...
Status
Completed
Location
University of North Carolina
Start Date
2009-09
Trial ID
NCT01031706
Treatments Being Tested
The goal of this clinical trial is to learn whether elénzia CONTROL®, a nut...
Status
Not Yet Recruiting
Location
Elénzia
Start Date
2026-09
Trial ID
NCT07789223
Treatments Being Tested
This phase II trial studies how well TPIV100 and sargramostim work in treat...
Status
Unknown
Location
Mayo Clinic in Arizona
Start Date
2020-02-20
Trial ID
NCT04197687
This phase 2, single-blind, placebo-controlled study will evaluate the onse...
Status
Terminated
Location
Capital Nephrology Associates, PA
Start Date
2017-01
Trial ID
NCT03018067
The purpose of this pilot study is to evaluate the effects of 4 weeks of da...
Status
Recruiting
Location
Biofortis
Start Date
2024-07-31
Trial ID
NCT06548048
Treatments Being Tested
The study is a randomized, double blind, placebo-controlled, non-comparativ...
Status
Recruiting
Location
Nationales Centrum für Tumorerkrankungen
Start Date
2026-05-29
Trial ID
NCT07387198